Menu
Back to Journals » Clinical Epidemiology » Volume 5 » Issue 1
Screening for severe combined immunodeficiency in neonates
Authors Kelly BT, Tam JS, Verbsky JW, Routes JM
Received 23 May 2013
Accepted for publication 15 July 2013
Published 16 September 2013 Volume 2013:5(1) Pages 363—369
DOI https://doi.org/10.2147/CLEP.S48890
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Brian T Kelly,1 Jonathan S Tam,1 James W Verbsky,1,2 John M Routes1,2
1Department of Pediatrics, 2Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI, USA
Abstract: Severe combined immunodeficiency (SCID) is a rare disease that severely affects the cellular and humoral immune systems. Patients with SCID present with recurrent or severe infections and often with chronic diarrhea and failure to thrive. The disease is uniformly fatal, making early diagnosis essential. Definitive treatment is hematopoietic stem cell transplantation, with best outcomes prior to 3.5 months of age. Newborn screening for SCID using the T-cell receptor excision circle assay has revolutionized early identification of infants with SCID or severe T-cell lymphopenia.
Keywords: severe combined immunodeficiency, T-cell receptor excision circle, newborn screening, primary immunodeficiency
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.